INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development, net	$ 1,867	$ 4,008	$ 13,509	$ 11,018
General and administrative	2,618	1,543	6,684	4,318
Operating loss	(4,485)	(5,551)	(20,193)	(15,336)
Financial expenses (income), net	3	83	(197)	225
Net loss	$ (4,488)	$ (5,634)	$ (19,996)	$ (15,561)
Basic and diluted net loss per share from continuing operations	$ (0.14)	$ (0.25)	$ (0.70)	$ (0.72)
Weighted average number of shares outstanding used in computing basic and diluted net loss per share	31,154,101	22,254,993	28,695,540	21,630,007